Education
About Us
Working with TipRanks
Follow Us
Xilio Therapeutics Inc (XLO)
NASDAQ:XLO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.34M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 6.34M | $ 0.00 | $ 0.00 | $ -1.50M | $ -1.06M |
| Operating Income | $ -60.58M | $ -79.13M | $ -89.15M | $ -75.04M | $ -54.56M |
| EBITDA | $ -58.00M | $ -77.23M | $ -87.30M | $ -73.70M | $ -53.55M |
| Net Income | $ -58.24M | $ -76.40M | $ -88.22M | $ -75.80M | $ -55.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 55.29M | $ 44.70M | $ 120.39M | $ 198.05M | $ 19.24M |
| Total Assets | $ 71.08M | $ 60.93M | $ 139.16M | $ 221.60M | $ 36.32M |
| Total Debt | $ 8.14M | $ 11.46M | $ 19.94M | $ 20.74M | $ 21.89M |
| Net Debt | $ -47.15M | $ -33.25M | $ -100.45M | $ -177.32M | $ 2.65M |
| Total Liabilities | $ 53.48M | $ 24.10M | $ 33.52M | $ 36.17M | $ 41.60M |
| Stockholders' Equity | $ 17.60M | $ 36.83M | $ 105.65M | $ 185.43M | $ -5.29M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.41M | $ -69.11M | $ -77.59M | $ -81.85M | $ -38.28M |
| Operating Cash Flow | $ -18.38M | $ -68.62M | $ -75.72M | $ -80.75M | $ -36.09M |
| Investing Cash Flow | $ -36.00K | $ -486.00K | $ -1.87M | $ -1.10M | $ -2.19M |
| Financing Cash Flow | $ 29.20M | $ -6.55M | $ -69.00K | $ 260.67M | $ 10.03M |
Xilio Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.